BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34160753)

  • 1. Scipion PKPD: an Open-Source Platform for Biopharmaceutics, Pharmacokinetics and Pharmacodynamics Data Analysis.
    Sorzano COS; Fonseca-Reyna Y; de la Cruz-Moreno MAP
    Pharm Res; 2021 Jul; 38(7):1169-1178. PubMed ID: 34160753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scipion-Chem: An Open Platform for Virtual Drug Screening.
    Del Hoyo D; Salinas M; Lomas A; Ulzurrun E; Campillo NE; Sorzano CO
    J Chem Inf Model; 2023 Dec; 63(24):7873-7885. PubMed ID: 38052452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PhysiPKPD: A pharmacokinetics and pharmacodynamics module for PhysiCell.
    Bergman D; Marazzi L; Chowkwale M; Maheshvare M D; Bidanta S; Mapder T; Li J
    GigaByte; 2022; 2022():gigabyte72. PubMed ID: 36950142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.
    Rinaki E; Valsami G; Macheras P
    Pharm Res; 2003 Dec; 20(12):1917-25. PubMed ID: 14725354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
    Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
    Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.
    Koch G; Krzyzanski W; Pérez-Ruixo JJ; Schropp J
    J Pharmacokinet Pharmacodyn; 2014 Aug; 41(4):291-318. PubMed ID: 25142056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The developability classification system: application of biopharmaceutics concepts to formulation development.
    Butler JM; Dressman JB
    J Pharm Sci; 2010 Dec; 99(12):4940-54. PubMed ID: 20821390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Electron Microscopy Normal Mode Analysis with Scipion.
    Harastani M; Sorzano COS; Jonić S
    Protein Sci; 2020 Jan; 29(1):223-236. PubMed ID: 31693263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
    Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
    Zhang T; Heimbach T; Lin W; Zhang J; He H
    J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.
    Eckernäs E; Tannergren C
    Mol Pharm; 2021 Apr; 18(4):1699-1710. PubMed ID: 33720733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration.
    O'Dwyer PJ; Box KJ; Dressman J; Griffin BT; Henze LJ; Litou C; Pentafragka C; Statelova M; Vertzoni M; Reppas C
    J Pharm Pharmacol; 2021 Mar; 73(4):437-446. PubMed ID: 33793836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
    Gukasyan HJ; Hailu S; Karami TK; Graham R
    Drug Discov Today; 2019 Aug; 24(8):1587-1597. PubMed ID: 30959112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound-The Venetoclax Story.
    Emami Riedmaier A; Lindley DJ; Hall JA; Castleberry S; Slade RT; Stuart P; Carr RA; Borchardt TB; Bow DAJ; Nijsen M
    J Pharm Sci; 2018 Jan; 107(1):495-502. PubMed ID: 28993217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gPKPDSim: a SimBiology
    Hosseini I; Gajjala A; Bumbaca Yadav D; Sukumaran S; Ramanujan S; Paxson R; Gadkar K
    J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):259-275. PubMed ID: 29302838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.